News
German software company PVRadar Labs has released a Python programming package for solar asset owners and engineers that want to build site-specific models.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Although there is currently no cure for multiple sclerosis, it’s not a fatal condition. Here’s what you need to know about MS and life expectancy.
Huntington's disease is a devastating illness, although its autosomal-dominant genetic transmission allows a unique opportunity to study apparently healthy individuals before manifest disease.
Based on the ITC, which included the pivotal Phase 3 Vivacity-MG3 study data, IMAAVY showed comparable onset of symptom relief at Week 1 and showed consistent and sustained disease control with ...
Explore the latest pharmaceutical trends and predictions for 2025 from an incoming CEO's perspective. Stay ahead of the curve and prepare your organisation for the future.
Alzheimer's disease affects an estimated 1 in 10 people over age 65. Find in-depth Alzheimer's information ...
Graft versus host disease can be a very serious complication of a stem cell transplant. Learn the signs, the causes, and about the advances in medicine that can help your body fight it off and ...
Learn about how predictive analytics works, the types, benefits, use cases, and top tools. Predictive analytics is a process that uses statistics and modeling techniques to make informed decisions ...
Hosted on MSN27d
BTK Inhibitors for Multiple Sclerosis - MSNBTK inhibitors are an established therapeutic class in several oncologic and hematologic disorders, and second-generation agents are being actively investigated in MS and other auto-immune diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results